Welcome to Harmoniously Where Healing Begins

At Harmoniously, we understand because we've been there. Our journey through the challenges of mental health has led us to a breakthrough that we now share with you—ketamine therapy, a beacon of hope for enduring wellness.

Welcome to Harmoniously

Where Healing Begins

At Harmoniously, we understand because we've been there. Our journey through the challenges of mental health has led us to a breakthrough that we now share with you—ketamine therapy, a beacon of hope for enduring wellness.

What We Offer

Experience personalized medicine that treats the mind, body, and spirit.


Dive into the heart of our offerings—ketamine therapy—enriched by scientific discovery and clinical excellence. This innovative treatment stands as a testament to our commitment to offer rapid relief and a renewed sense of hope for those facing the toughest mental health battles.

Psychiatric clinician appointments

At-Home Ketamine Treatments

20-min Health & Wellness Coaching

Mindfulness Meditation Circles

Psychedelic Integration Circles

Customizable Wellness Meal Plan

Mission Statement

Empowering Your Path to Mental Wellness

Our mission is to offer hope and transformative healing to those battling depression, anxiety, and other mental health challenges, through innovative ketamine therapy integrated with holistic wellness practices.

Patient Experience

A Journey of Transformation

Lucy's testimonial image

Meet Lucy

“I recently completed a ketamine treatment series at Harmoniously, which has been transformative for my long-standing anxiety and depression. Previous therapies and medications had little effect, but from the first session of ketamine treatment, I noticed a significant mood enhancement and reduction in anxiety, with depression lifting swiftly.

The supportive staff, particularly Rachel and Sean, ensured a comfortable and well-informed experience. As the treatment progressed, my mental clarity improved remarkably, enhancing my engagement with work and relationships, and restoring my control over life. I am immensely grateful to Harmoniously for this life-changing experience and highly recommend it to anyone facing similar challenges.”

Sean Carr testimonial image

Meet Sean Carr

“Ketamine therapy has been a game-changer for me. After a surgery left me traumatized and hospitalized, it helped me reclaim my life within six weeks. Living with drug-resistant depression and anxiety, ketamine therapy not only reduced my need for daily medications but also synergized with my longevity regimen, offering profound neuroplastic and neuroprotective effects. It’s not just a treatment—it’s a lifeline to hope, healing, and resilience.”

Kerri testimonial image

Meet Kerri

“Working with Harmoniously has been truly transformative. It’s like having a personal caretaker for your mind. Battling anxiety has been my ongoing challenge, but through the combination of ketamine treatment and psychosynthesis coaching with Melissa, I’ve begun to unravel and heal the root causes of my anxiety. Now, I feel like I have my life back!”

MONTHLY

Harmoniously Essential Wellness Package

Monthly Program

  • 1 Psychiatric Intake Appointment

  • 1 follow-up visit

  • 6 At-Home Ketamine Treatments

  • (1) 20-min Coaching Session

  • Mindfulness Meditation Circles

  • Psychedelic Integration Circles

$599 /month

Innovation and Science

The Science of Hope

Rooted in cutting-edge research, ketamine therapy's power to enhance brain plasticity and foster healing is a revolution in mental health care. Our approach is informed by the latest scientific insights, ensuring that your path to recovery is guided by knowledge and a deep understanding of the brain's potential for renewal.

Comprehensive Care Approach

Beyond Therapy: A Holistic Promise

Our care extends beyond the therapy session. Integrating personalized coaching, nutritional guidance, and mindfulness practices, we address mental health from all angles. Inspired by our own healing journeys, we've crafted a holistic care model that nurtures mind, body, and spirit.

It’s time to take back control of your life & begin to feel happy again

Are you ready to explore a new horizon in mental health care? Contact us to discover how ketamine therapy can illuminate your path to wellness. Your journey of transformation starts here.

It’s time to take back control of your life & begin to feel happy again

Are you ready to explore a new horizon in mental health care? Contact us to discover how ketamine therapy can illuminate your path to wellness. Your journey of transformation starts here.

articles

Our Latest Blog

MindMed's LSD Drug Given Breakthrough Therapy Status by FDA to Treat Anxiety

MindMed's LSD Drug Given Breakthrough Therapy Status by FDA to Treat Anxiety

June 21, 20243 min read

MindMed's LSD Drug Given Breakthrough Therapy Status by FDA to Treat Anxiety

Latest

May 30, 2024

4 min read

The U.S. Food and Drug Administration (FDA) recently awarded a Breakthrough Therapy designation to MM120, an investigational drug being developed by MindMed, signaling a major leap forward in the treatment of Generalized Anxiety Disorder (GAD). This designation is not only a significant milestone for MindMed, a company at the forefront of psychedelics-inspired medicines, but also marks a crucial step in the acknowledgment and support of innovative treatments within the medical and pharmaceutical landscapes. In this blog post, we delve into the importance of this designation for MM120, its potential impacts on patients and the healthcare system, and the broader implications for drug development and regulatory endorsement of novel therapies.

Understanding Breakthrough Therapy Designation

The FDA's Breakthrough Therapy designation aims to expedite the development and review of drugs that are intended to treat a serious condition and where preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies. This prestigious status granted to MM120 underscores the FDA's recognition of its potential to significantly improve treatment outcomes for patients with GAD.

Insight into MM120

MM120 is a novel compound inspired by the psychedelic substance LSD, designed by MindMed to address the unmet needs in the treatment of GAD, a condition characterized by persistent and excessive worry that can disrupt daily life. Unlike traditional treatments for GAD, which can vary in effectiveness and often come with unwanted side effects, MM120 offers a promising alternative based on its unique mechanism of action derived from its psychedelic origins. Early clinical trials have demonstrated MM120's effectiveness in reducing symptoms of anxiety, positioning it as a potentially groundbreaking option for individuals suffering from GAD.

Implications for Patients and Healthcare

For patients battling GAD, the development of MM120 under the Breakthrough Therapy designation could represent a beacon of hope. Earlier access to MM120 could translate into a more effective and tolerable treatment option, potentially transforming the management of GAD and enhancing quality of life for countless individuals. Moreover, the expedited development and review process facilitated by this designation means that critical information about the drug's efficacy and safety can reach patients, healthcare providers, and policymakers more swiftly, potentially leading to broader access upon approval.

The healthcare system stands to benefit from innovative treatments like MM120 by addressing gaps in care, potentially reducing long-term costs associated with managing chronic anxiety disorders. Such innovations encourage further research and development, creating a more vibrant and responsive healthcare ecosystem capable of meeting the complex needs of patients with mental health conditions.

Broader Context: Supporting Innovation in Drug Development

The Breakthrough Therapy designation for MM120 reflects a wider trend in the pharmaceutical industry toward recognizing and fostering innovative treatments, especially in areas like mental health and neurological disorders where traditional options may be limited. This trend underscores the importance of exploring new therapeutic frontiers, including psychedelics-inspired medicines, and highlights the FDA's openness to facilitating novel treatments that show promise in addressing unmet medical needs.

Challenges and Future Directions

Despite the optimism surrounding MM120's designation, several challenges lie ahead. MindMed must continue to demonstrate the drug's safety and efficacy through comprehensive clinical trials to secure FDA approval. Integrating MM120 into the healthcare system will involve navigating insurance coverage, provider training, and ensuring patient access. Additionally, meeting the FDA's accelerated review timelines demands significant resources and careful planning from MindMed, requiring a delicate balance with other projects and operational considerations.

The FDA's Breakthrough Therapy designation for MM120 represents a pivotal development for MindMed and a hopeful advancement for patients with GAD. It highlights the critical role of innovative drug development in addressing serious health conditions and the FDA's commitment to supporting therapies that could significantly improve patient outcomes. As MM120 progresses through clinical trials, its journey from a novel psychedelic-inspired compound to a potential paradigm shift in anxiety treatment encapsulates the challenges, opportunities, and complexities of bringing transformative medical innovations to market. The path of MM120 underscores the evolving landscape of pharmaceuticals and mental health care, promising new horizons for patients seeking effective and humane treatments for anxiety disorders.

Back to Blog
MindMed's LSD Drug Given Breakthrough Therapy Status by FDA to Treat Anxiety

MindMed's LSD Drug Given Breakthrough Therapy Status by FDA to Treat Anxiety

June 21, 20243 min read

MindMed's LSD Drug Given Breakthrough Therapy Status by FDA to Treat Anxiety

Latest

May 30, 2024

4 min read

The U.S. Food and Drug Administration (FDA) recently awarded a Breakthrough Therapy designation to MM120, an investigational drug being developed by MindMed, signaling a major leap forward in the treatment of Generalized Anxiety Disorder (GAD). This designation is not only a significant milestone for MindMed, a company at the forefront of psychedelics-inspired medicines, but also marks a crucial step in the acknowledgment and support of innovative treatments within the medical and pharmaceutical landscapes. In this blog post, we delve into the importance of this designation for MM120, its potential impacts on patients and the healthcare system, and the broader implications for drug development and regulatory endorsement of novel therapies.

Understanding Breakthrough Therapy Designation

The FDA's Breakthrough Therapy designation aims to expedite the development and review of drugs that are intended to treat a serious condition and where preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies. This prestigious status granted to MM120 underscores the FDA's recognition of its potential to significantly improve treatment outcomes for patients with GAD.

Insight into MM120

MM120 is a novel compound inspired by the psychedelic substance LSD, designed by MindMed to address the unmet needs in the treatment of GAD, a condition characterized by persistent and excessive worry that can disrupt daily life. Unlike traditional treatments for GAD, which can vary in effectiveness and often come with unwanted side effects, MM120 offers a promising alternative based on its unique mechanism of action derived from its psychedelic origins. Early clinical trials have demonstrated MM120's effectiveness in reducing symptoms of anxiety, positioning it as a potentially groundbreaking option for individuals suffering from GAD.

Implications for Patients and Healthcare

For patients battling GAD, the development of MM120 under the Breakthrough Therapy designation could represent a beacon of hope. Earlier access to MM120 could translate into a more effective and tolerable treatment option, potentially transforming the management of GAD and enhancing quality of life for countless individuals. Moreover, the expedited development and review process facilitated by this designation means that critical information about the drug's efficacy and safety can reach patients, healthcare providers, and policymakers more swiftly, potentially leading to broader access upon approval.

The healthcare system stands to benefit from innovative treatments like MM120 by addressing gaps in care, potentially reducing long-term costs associated with managing chronic anxiety disorders. Such innovations encourage further research and development, creating a more vibrant and responsive healthcare ecosystem capable of meeting the complex needs of patients with mental health conditions.

Broader Context: Supporting Innovation in Drug Development

The Breakthrough Therapy designation for MM120 reflects a wider trend in the pharmaceutical industry toward recognizing and fostering innovative treatments, especially in areas like mental health and neurological disorders where traditional options may be limited. This trend underscores the importance of exploring new therapeutic frontiers, including psychedelics-inspired medicines, and highlights the FDA's openness to facilitating novel treatments that show promise in addressing unmet medical needs.

Challenges and Future Directions

Despite the optimism surrounding MM120's designation, several challenges lie ahead. MindMed must continue to demonstrate the drug's safety and efficacy through comprehensive clinical trials to secure FDA approval. Integrating MM120 into the healthcare system will involve navigating insurance coverage, provider training, and ensuring patient access. Additionally, meeting the FDA's accelerated review timelines demands significant resources and careful planning from MindMed, requiring a delicate balance with other projects and operational considerations.

The FDA's Breakthrough Therapy designation for MM120 represents a pivotal development for MindMed and a hopeful advancement for patients with GAD. It highlights the critical role of innovative drug development in addressing serious health conditions and the FDA's commitment to supporting therapies that could significantly improve patient outcomes. As MM120 progresses through clinical trials, its journey from a novel psychedelic-inspired compound to a potential paradigm shift in anxiety treatment encapsulates the challenges, opportunities, and complexities of bringing transformative medical innovations to market. The path of MM120 underscores the evolving landscape of pharmaceuticals and mental health care, promising new horizons for patients seeking effective and humane treatments for anxiety disorders.

Back to Blog

See the Transformation

I've got answers.

Do you accept insurance?

No, at this time we do not accept insurance for at-home Ketamine treatment.

Harmoniously is a community platform for connecting people with a passion for improving their mental and physical wellness, with the clinicians and practitioners who can help them achieve their own personal goals around mental and physical health, vitality, and longevity.

Our focus is on "Health-care" not "Sick-care" we strive to provide the tools needed to help you design your own vision of what a healthy lifestyle means alongside the expert guidance of our interdisciplinary team of . In order to increase accessibility to healing alternative medical treatments we offer reduced-cost packages for those with a financial need.

How is Ketamine administered at home?

At-home ketamine treatments are delivered to your home from one of our compounding pharmacy partners. We offer two forms of the medication, either a Rapid Dissolve Tab (or RTD) which quickly dissolves under your tongue or a Trochee form which is a small lozenge that slowly dissolves between your cheek and gum.

You will administer the medicine yourself and you MUST always have a peer support adult physically present each time you administer treatment. This is to ensure your safety and comfort in the event you need physical assistance or emotional support.

With both you will hold the medicine in your mouth for a few minutes and then spit it out. You clinciain will work with you to explain how long you should hold the medicine and how to properly and safely dispose of it once it's spit out.

Is Ketamine Therapy Safe

Ketamine treatment has been shown to be a safe and effective treatment for most people. However, there are some conditions that are not a safe option for at-home treatment. Some of these include:


- Diagnosed with a psychotic disorder such as schizophrenia or schizoaffective disorder

- Considered or attempted suicide in the last year or planned self harm in the last month

- Biological female who is pregnant, planning to become pregnant, or breast feeding

- Currently taking Opioid containing drugs such as Buprenophine, Suboxone, Sublocade

- Anyone under 18 years of age

Other requirements for treatment include:


- Having an adult peer support person who is able to be physically present each time you administer your ketamine treatment

- Have the ability to work with technology through our telehealth platform

- Be in a private location, and not in an automobile even if stopped, for your appointment with a prescribing clinician

- Commit to always being in a safe location either seated in a chair or in bed in an slightly elevated position.

What if I can't afford treatment?

We started Harmoniously with the goal of creating greater equity in access to groundbreaking treatments like at-home ketamine assisted therapy. However, we know that the cost of treatment may be prohibitive for some people. If you are concerned with affordability you can call to speak with a representative about sliding scale options we may be able to offer.

We honor your journey with the utmost

respect for privacy and compliance.

Your safety and trust are our priorities.

We honor your journey with the utmost

respect for privacy and compliance.

Your safety and trust are our priorities.

Who we are

Harmonizing mind, body, and spirit to elevate our collective consciousness

Harmoniously.com is a public benefit corporation committed to promoting greater equity in access to psychedelic medicines, particularly in the BIPOC and LGBTQ+ Communities and we support indigenous reciprocity to support the communities that have protected the knowledge of how to work with these medicines for thousands of years.

Can’t come to us? We’ll come to you!

Harmoniously connects individuals with medical professionals. It's a platform, not a provider, and doesn't offer medical advice.

Harmoniously connects individuals with medical professionals. It's a platform, not a provider, and doesn't offer medical advice.

© 2024 GIVE HARMONIOUSLY INC a 501(c)(3) Non-Profit Organization